Research, Select, & Monitor Tuesday, May 21, 2019 6:48:46 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
AEterna Zentaris Inc$3.22$.041.26%

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  AEterna Zentaris Inc vs Chemicals - Major Diversified

AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead oncology program is a Phase 2 trial in endometrial and ovarian cancer with AEZS-108, a targeted cytotoxic peptide conjugate. Other lead compounds include ozarelix for BPH and prostate cancer as well as perifosine for multiple cancers.

Looking at a few key industries, such as chemical manufacturing, one can usually summarize the strength of a nationís economy. So many industries rely on the raw products of these companies. Fuel additives and detergents are probably the most common encounter we have with products from these firms. They also produce pharmaceuticals, polymers, resins, monomers, plastics, agricultural chemicals, and industrial gases. Just a few of the industries that use these items are aerospace, beverage, electronic, food processing, automotive, and construction.
 Totals Company Industry
  Sales: $26.9 Mil $80,772.4 Mil
  Market Cap: $52.3 Mil $176,176.8 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
  Historic Revenue: 2,821.7% 16.8%
  Estimated Revenue: 123.0% .2%
  Historic Earnings: N/A 25.0%
  Estimated Earnings: N/A 12.2%
  Stock Price (1 Year): 69.1% (20.4%)
  Cash per Share: 86.5% (7.3%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: .0 13.7
  Price-to-Sales: 1.9 N/A
  Price-to-Book: 27.4 2.8
  Dividend Yield: N/A N/A
  Market Cap: $52.3 Mil $22,022.1 Mil
  Net Margin: 15.6% 13.5%
  Gross Margin: 92.2% 36.2%
  Return on Equity: 2.2 .2
  Return on Assets: .2 .1
  Balance Sheet
  Current Ratio: 2.9 1.6
  Quick Ratio: 2.9 1.1
  Cash Ratio: 2.6 .3
  Debt-to-Equity: 12.1 1.7
  Interest Coverage: N/A .6
  Relative-Strength Index: N/A N/A

 Other companies in Chemicals - Major Diversified Price Market Cap
  L'Air Liquide ADR  (AIQUY) $25.29 $54,176.7 Mil
  Air Products & Chemicals, Inc.  (APD) $205.41 $45,477.8 Mil
  Henkel KGaA  (HENKY) $22.13 $22,997.1 Mil
  Akzo Nobel N.V.  (AKZOY) $28.40 $19,424.7 Mil
  Celanese Corp  (CE) $99.54 $12,761.0 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2019 All rights reserved.